Luliford Cream contains Luliconazole 1% w/w, an imidazole antifungal agent indicated for the topical treatment of superficial fungal infections such as dermatophytosis, tinea corporis, tinea cruris, and tinea pedis. Luliconazole exhibits potent fungicidal activity by inhibiting the synthesis of ergosterol, an essential component of fungal cell membranes, thereby disrupting membrane integrity and leading to fungal cell death. The cream formulation ensures targeted delivery to affected skin areas, promoting rapid symptom relief including reduction of itching, redness, and scaling. Luliford Cream is typically applied once daily to the clean, dry affected area for a duration prescribed by a healthcare professional, generally ranging from one to two weeks depending on the severity and type of infection. It is well-tolerated with minimal systemic absorption, reducing the risk of systemic side effects. Common adverse reactions may include mild local irritation, burning sensation, or erythema at the application site. Luliford Cream should be used with caution in patients with known hypersensitivity to luliconazole or any of the cream excipients. It is contraindicated in cases of bacterial or viral skin infections. Proper adherence to the treatment regimen is essential to prevent recurrence and achieve optimal therapeutic outcomes.